The solution for injection contains the active substance follitropin beta, produced by genetic engineering of a Chinese hamster ovary (CHO) cell line.
Süstelahus sisaldab toimeainena follitropiin beetat, mis on toodetud insenergeneetiliselt hiina hamstri ovaariumide (CHO) rakuliinist.